Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling - PubMed
- ️Invalid Date
. 2015 Aug;194(2):539-46.
doi: 10.1016/j.juro.2015.01.079. Epub 2015 Jan 24.
Affiliations
- PMID: 25623744
- DOI: 10.1016/j.juro.2015.01.079
Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling
Tobias Haber et al. J Urol. 2015 Aug.
Abstract
Purpose: Bone metastasis develops in 30% of all patients with renal cell carcinoma. We elucidated the mechanisms that lead to and predict bone metastasis of renal cell carcinoma.
Materials and methods: Nine renal cell carcinoma primary cell lines and 30 renal cell carcinoma tissue specimens (normal and tumor tissue) were collected from 3 patients with no metastasis and 10 with lung or bone metastasis within 5 years after nephrectomy. Cell migration was analyzed in a Boyden chamber and proliferation was assessed by bromodeoxyuridine incorporation. Adhesion to fibronectin, and collagen I and IV was determined after cell staining. The expression and/or activity of cellular signaling molecules was quantified by Western blot.
Results: Compared to renal cell carcinoma cells from patients without metastasis, the migration of cells from patients with bone metastasis was enhanced 13.5-fold (p = 0.034), and adhesion to fibronectin and collagen I was enhanced 5.8-fold and 6.1-fold (p = 0.002 and 0.014, respectively). In general proliferation was decreased in metastasizing cells. In accordance with these results we detected higher activity of AKT (p = 0.011) and FAK (p = 0.054), higher integrin α5 expression (p = 0.052) and lower PTEN expression in primary cells from patients with bone metastasis compared to nonmetastasizing cells. An almost similarly altered expression pattern was also observed in the renal cell carcinoma tissue specimens and the normal renal tissue of patients with bone metastasis.
Conclusions: We describe evidence that molecular predispositions determine the potential for bone metastasis to develop in renal cell carcinoma, which may serve as prognostic markers after initial tumor detection.
Keywords: bone and bones; carcinoma; kidney; neoplasm metastasis; renal cell; signal transduction.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Wang H, Chen B, Duan B, Zheng J, Wu X. Wang H, et al. Mol Med Rep. 2016 Oct;14(4):3343-9. doi: 10.3892/mmr.2016.5589. Epub 2016 Aug 4. Mol Med Rep. 2016. PMID: 27498834
-
Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
Schneider E, Keppler R, Prawitt D, Steinwender C, Roos FC, Thüroff JW, Lausch E, Brenner W. Schneider E, et al. Int J Oncol. 2011 Mar;38(3):823-31. doi: 10.3892/ijo.2010.893. Epub 2010 Dec 30. Int J Oncol. 2011. PMID: 21206972
-
Liu S, Ma X, Ai Q, Huang Q, Shi T, Zhu M, Wang B, Zhang X. Liu S, et al. Urol Oncol. 2013 Aug;31(6):938-48. doi: 10.1016/j.urolonc.2011.07.006. Epub 2011 Oct 10. Urol Oncol. 2013. PMID: 21993533
-
Joeckel E, Haber T, Prawitt D, Junker K, Hampel C, Thüroff JW, Roos FC, Brenner W. Joeckel E, et al. Mol Cancer. 2014 Feb 28;13:42. doi: 10.1186/1476-4598-13-42. Mol Cancer. 2014. PMID: 24576174 Free PMC article.
-
Choufani E, Diligent J, Galois L, Mainard D. Choufani E, et al. J Am Podiatr Med Assoc. 2011 May-Jun;101(3):265-8. doi: 10.7547/1010265. J Am Podiatr Med Assoc. 2011. PMID: 21622639 Review.
Cited by
-
Soupir AC, Hayes MT, Peak TC, Ospina O, Chakiryan NH, Berglund AE, Stewart PA, Nguyen J, Segura CM, Francis NL, Echevarria PMR, Chahoud J, Li R, Tsai KY, Balasi JA, Peres YC, Dhillon J, Martinez LA, Gloria WE, Schurman N, Kim S, Gregory M, Mulé J, Fridley BL, Manley BJ. Soupir AC, et al. bioRxiv [Preprint]. 2023 Nov 17:2023.11.16.567457. doi: 10.1101/2023.11.16.567457. bioRxiv. 2023. PMID: 38014063 Free PMC article. Updated. Preprint.
-
Sethakorn N, Heninger E, Sánchez-de-Diego C, Ding AB, Yada RC, Kerr SC, Kosoff D, Beebe DJ, Lang JM. Sethakorn N, et al. Cancers (Basel). 2022 Feb 1;14(3):757. doi: 10.3390/cancers14030757. Cancers (Basel). 2022. PMID: 35159026 Free PMC article. Review.
-
Integrin α5 triggers the metastatic potential in renal cell carcinoma.
Breuksch I, Prosinger F, Baehr F, Engelhardt FP, Bauer HK, Thüroff JW, Heimes AS, Hasenburg A, Prawitt D, Brenner W. Breuksch I, et al. Oncotarget. 2017 Nov 18;8(64):107530-107542. doi: 10.18632/oncotarget.22501. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296184 Free PMC article.
-
Bone Metastasis from Renal Cell Carcinoma.
Chen SC, Kuo PL. Chen SC, et al. Int J Mol Sci. 2016 Jun 22;17(6):987. doi: 10.3390/ijms17060987. Int J Mol Sci. 2016. PMID: 27338367 Free PMC article. Review.
-
Research progress of bone metastases: From disease recognition to clinical practice.
Yang W, Pan Q, Huang F, Hu H, Shao Z. Yang W, et al. Front Oncol. 2023 Jan 25;12:1105745. doi: 10.3389/fonc.2022.1105745. eCollection 2022. Front Oncol. 2023. PMID: 36761418 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous